Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Thiolated cyclodextrin-based nanoparticles effectively deliver Minoxidil for scalp treatment without causing skin irritation.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Certain hormone treatments can improve acne and related conditions in women.

Retinoids are effective for acne but can cause serious side effects.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The method improves acne treatment by enhancing drug delivery and reducing skin irritation.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Topical corticosteroids are effective for skin conditions but can have side effects.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

The combined therapy was effective and safe for children with severe alopecia areata.

Topical sensitizers have mixed success in treating alopecia areata.

A 13-year-old boy with a rare scalp condition improved significantly with isotretinoin, minoxidil, oral steroids, and antiseptic shampoo.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

New acne treatments show promise as alternatives to traditional therapies.

The compound was successfully made and shows potential for treating prostate cancer.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.